GSK’s Zejula-Jemperli combo met its primary endpoint in a trial investigating the drugs in first-line advanced ovarian cancer, but missed…
Author: Katherine Lewin
The high-dose version of Regeneron’s eye treatment Eylea hit its primary endpoint in a late-stage study for macular edema following…
The US Health Resources and Services Administration on Friday warned Sanofi against implementing its planned rebate model for some of…
PureTech Health unveiled positive Phase 2b data on Monday for its idiopathic pulmonary fibrosis drug, which showed it can reduce…
Bicycle Therapeutics shared several batches of data for its bicyclic toxin conjugate in metastatic urothelial cancer, non-small cell lung cancer…
The European Medicines Agency’s human medicines committee (CHMP) handed down 17 recommendations for drug approvals on Friday but said a…
Another trial for SIGA Technologies’ mpox antiviral has failed, and all enrollment has been stopped, the NIH’s National Institute of…
Relay Therapeutics’ stock {$RLAY} rose about 6% on Wednesday morning after it released positive interim data for its PI3Kα inhibitor…
NewAmsterdam Pharma’s cardio drug succeeded in a third readout this year, showing that obicetrapib could lower a type of lipoprotein…
Cardiff Oncology announced an oversubscribed $40 million offering on Tuesday after it released positive data from a mid-stage trial investigating…